ERBB2 and breast carcinoma: Accordingly, a recent study also analysing anti-Yo PCD OT samples did not find HER2 overexpression in anti-Yo PCD OT samples at protein level.3 These results suggest that the oncogenesis mechanisms related to OT or breast cancer with anti-Yo PCD are different.